Document is current
Any future updates will be listed below
-
Authors
Kessler, Carolina
von Brandenstein, Melanie
Klümper, Niklas
Krausewitz, Philipp
Storz, Enno
Rieger, Constantin
Sperber, Laurenz
Paffenholz, Pia
Tolkach, Yuri
Wirtz, Ralph
Eckstein, Markus
Heidenreich, Axel
Weiten, Richard https://orcid.org/0009-0002-7216-1033
-
Funding
Funding for this research was provided by:
Universitätsklinikum Köln
- License Information
-
More Information
Article History
Received: 14 August 2024
Accepted: 8 August 2025
First Online: 1 September 2025
Declarations
:
: NK: Personal fees, travel costs, and speaker’s honoraria from Astellas, Novartis, Ipsen, Photocure, MSD. PK: Personal fees, travel costs, and speaker’s honoraria from Bayer, Janssen-Cilag, Medac. ME: Personal fees, travel costs and speaker’s honoraria from MSD, AstraZeneca, Janssen-Cilag, Cepheid, Roche, Astellas, Diaceutics; research funding from AstraZeneca, Janssen-Cilag, STRATIFYER, Cepheid, Roche, Gilead; advisory roles for Diaceutics, MSD, AstraZeneca, Janssen-Cilag, GenomicHealth. All other authors declare no conflict of interest.
: The study received approval from the Ethics Committee of the Medical Faculty at the University of Cologne (approval number: 23-1178) and was conducted in adherence to the Declaration of Helsinki.
: All patients provided written informed consent.
